About Breast implant-associated lymphoma (BIA-ALCL)
Breast implant-associated anaplastic large cell lymphoma is a cancer of the immune system that can develop in the scar tissue or fluid surrounding an implant. It is not breast cancer. Risk is higher with textured implants than with smooth implants.
Changes that need evaluation
Persistent swelling, a new mass, pain, or a change around an implant should be assessed. Bring your implant details and prior surgery records. Diagnosis requires medical evaluation and appropriate testing; an online description cannot establish the cause of a symptom.
Discussing implant management
The FDA does not recommend routine implant removal solely because of BIA-ALCL concern in patients without symptoms. Management changes when there are symptoms or a confirmed diagnosis. Discuss your implant type, individual history, monitoring, and the risks of additional surgery with your treating clinician.
Further reading: FDA questions and answers about BIA-ALCL.
Plan your consultation
Bring your goals, medical history, current medicines and supplements, and questions about recovery. Ask which options fit your health and anatomy, what each option can and cannot change, and what your written quote includes. Contact Monarch or call 404.250.3333.